The latest update is out from Sonnet BioTherapeutics Holdings ( (SONN) ).
Sonnet BioTherapeutics Holdings, Inc. is set to engage investors with a Corporate Presentation during the Virtual Investor Closing Bell Series, scheduled for September 9, 2024. The presentation materials are now accessible on the company’s website for those interested in the latest developments of this biopharmaceutical enterprise. The provided information, while furnished to the SEC, is not considered filed under U.S. securities laws and is not intended to be part of its formal filings unless explicitly stated in such documents.
See more insights into SONN stock on TipRanks’ Stock Analysis page.
